Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model

Imiquimod is an imidazoquinoline immune response modifier that is used in antiviral and antiallergic creams. Combination therapy using transcutaneous imiquimod and oral sorafenib was previously demonstrated to reduce the tumor burden of renal cell carcinoma growing cutaneously in a mouse model. In t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Karashima, Takashi, Udaka, Keiko, Niimura, Mayumi, Suzuki, Katsuhide, Osakabe, Hiroto, Shimamoto, Tsutomu, Fukata, Satoshi, Inoue, Keiji, Kuroda, Naoto, Seiki, Motoharu, Shuin, Taro
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494610/
https://ncbi.nlm.nih.gov/pubmed/28693290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6235
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados